Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Virtual Event

18 may 2020 10:00 a.m. - 20 may 2020 3:15 p.m.

(US Eastern Standard Time)

Fort Washington, PA 19034

Advertising and Promotion Regulatory Affairs Conference

Session 3: OPDP Research Update (Recorded)

Session Chair(s)

Kathryn  Aikin, PhD, MS

Kathryn Aikin, PhD, MS

Senior Social Science Analyst, Research Team Lead, OPDP, CDER

FDA, United States

Individual FDA/OPDP researchers will present findings from OPDP research studies. Attendees will gain a better understanding of the FDA/OPDP Research program and how it may contribute to knowledge, guidance, and policy development. This session is designed to educate attendees on the regulatory research FDA has done to help inform policy and guidance development.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand the holistic research agenda of FDA/OPDP
  • Provide the audience with a view into individual topic areas and how they fit together
  • Identify insight into results of recent research

Speaker(s)

Kathryn  Aikin, PhD, MS

Introduction to the OPDP Research Program

Kathryn Aikin, PhD, MS

FDA, United States

Senior Social Science Analyst, Research Team Lead, OPDP, CDER

Amie  O'Donoghue, PhD

Animation in Direct-to-Consumer Prescription Drug Television Advertising

Amie O'Donoghue, PhD

FDA, United States

Social Science Analyst, OPDP, OMP, CDER

Kevin R. Betts, PhD

Physician and Consumer Capability to Detect and Inclination to Report Deceptive Prescription Drug Promotion

Kevin R. Betts, PhD

FDA, United States

Social Science Analyst, OPDP, OMP, CDER

Helen W. Sullivan, PhD, MPH

Consumers’ Understanding of Oncology Clinical Endpoints: Focus Group Findings

Helen W. Sullivan, PhD, MPH

FDA, United States

Social Science Analyst, OPDP, OMP, CDER

Kathryn  Aikin, PhD, MS

Consumers’ Experience with and Attitudes Toward Direct-to-Consumer Prescription Drug Promotion: A Nationally Representative Survey - Selected Findings

Kathryn Aikin, PhD, MS

FDA, United States

Senior Social Science Analyst, Research Team Lead, OPDP, CDER

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.